Juan Andres
Director/Board Member en AVANTOR, INC. .
Fortuna: 983 210 $ al 29/02/2024
Perfil
El Sr. Juan Andrés es director independiente de Evelo Biosciences, Inc., director independiente de Avantor, Inc. y jefe de operaciones técnicas y calidad de Moderna, Inc. Es miembro del Consejo de Administración de Evelo Biosciences, Inc, Avantor, Inc y Ring Therapeutics, Inc. Anteriormente, el Sr. Andrés trabajó como Jefe Global de Operaciones Técnicas en Novartis AG y como Vicepresidente de Fabricación Farmacéutica y Dispositivos en Eli Lilly & Co. Se licenció en la Universidad de Alcalá de Henares.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
AVANTOR, INC.
0.01% | 11/05/2023 | 39 903 ( 0.01% ) | 983 210 $ | 29/02/2024 |
EVELO BIOSCIENCES, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Cargos activos de Juan Andres
Empresas | Cargo | Inicio |
---|---|---|
AVANTOR, INC. | Director/Board Member | 01/09/2019 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Antiguos cargos conocidos de Juan Andres.
Empresas | Cargo | Fin |
---|---|---|
EVELO BIOSCIENCES, INC. | Director/Board Member | 20/11/2023 |
MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
NOVARTIS AG | Chief Tech/Sci/R&D Officer | 01/06/2017 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2009 |
Formación de Juan Andres.
Universida de Alcalá de Henares | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 5 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
NOVARTIS AG | Health Technology |
EVELO BIOSCIENCES, INC. | Health Technology |
AVANTOR, INC. | Process Industries |
MODERNA, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |